Whoever wins the 3 May federal election should delay and re-consult on the incoming restrictions on Medicare rebates for vitamin B12 and urine tests, the AMA says.

The current government plans to limit MBS item 66839 for quantification of B12 markers such as holotranscobalamin or methylmalonic acid (schedule fee $42.95) to one claim per patient a year, starting 1 July.